# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-23-036702
Filing Date
2023-11-03
Accepted
2023-11-03 16:05:44
Documents
65
Period of Report
2023-09-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | vir-20230930.htm iXBRL | 10-Q | 1429265
7 | EX-10.1 | a20231103-q310qex101.htm | EX-10.1 | 55137
8 | EX-10.2 | a20231103-q310qex102.htm | EX-10.2 | 295282
9 | EX-10.3 | a20231103-q310qex103.htm | EX-10.3 | 136073
10 | EX-31.1 | a20231103-q310qex311.htm | EX-31.1 | 10767
11 | EX-31.2 | a20231103-q310qex312.htm | EX-31.2 | 10729
12 | EX-32.1 | a20231103-q310qex321.htm | EX-32.1 | 8117
| Complete submission text file | 0001628280-23-036702.txt |  | 6520653

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
2 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | vir-20230930.xsd | EX-101.SCH | 44180
3 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT | vir-20230930_cal.xml | EX-101.CAL | 74511
4 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT | vir-20230930_def.xml | EX-101.DEF | 171702
5 | XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | vir-20230930_lab.xml | EX-101.LAB | 585425
6 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | vir-20230930_pre.xml | EX-101.PRE | 354298
59 | EXTRACTED XBRL INSTANCE DOCUMENT | vir-20230930_htm.xml | XML | 636559

Mailing Address 1800 OWENS STREET SUITE 900 SAN FRANCISCO CA 94158
Business Address 1800 OWENS STREET SUITE 900 SAN FRANCISCO CA 94158 415-906-4324
Vir Biotechnology, Inc. (Filer) CIK: 0001706431 (see all company filings)

EIN.: 812730369 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39083 | Film No.: 231376325
SIC: 2836 Biological Products, (No Diagnostic Substances)